Key facts
- Notable investors include F-Prime Capital, Norwest, Hatteras Venture Partners, NuXcel, Treo Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for iRiva Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for iRiva Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About iRiva Medical
Developer of implantable neuromodulation technologies designed for treatment of chronic health conditions. The company integrates advanced stimulation systems, minimally invasive device architecture, clinician-guided therapy protocols, and patient-centric monitoring tools to address unmet clinical needs in chronic disease management, enabling healthcare providers to deliver targeted, scalable, and durable therapeutic interventions for large patient populations with persistent medical challenges.
- Sector
- Healthcare
- HQ
- Minneapolis, MN, United States
- Website
- irivamedical.com/
- Ownership
- Privately Held (backing)
iRiva Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in iRiva Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on iRiva Medical in its N-PORT filings yet. We sweep new filings monthly.